Abstract
A number of diseases such as the Alzheimer’s disease, Creutzfeldt-Jakob disease, type-2 diabetes are believed to be associated with the aggregation of proteins and amyloid peptides. In this mini-review we discuss general factors that govern the aggregation of polypeptide chains. It is shown that the extent of population of an ensemble of fibril-prone structures in the spectrum of conformations of an isolated protein, is the major determinant of fibril formation rates. Presently, available drugs help to mask the symptoms, but do not treat aggregation-associated diseases making it vital to develop drugs to cope them. Recent progress on design of topleads for the Alzheimer’s disease will be covered.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 IFMBE
About this paper
Cite this paper
Li, M.S., Tung, N.S. (2013). Computational Study of Diseases Associated with Protein Aggregation. In: Toi, V., Toan, N., Dang Khoa, T., Lien Phuong, T. (eds) 4th International Conference on Biomedical Engineering in Vietnam. IFMBE Proceedings, vol 49. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-32183-2_94
Download citation
DOI: https://doi.org/10.1007/978-3-642-32183-2_94
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-32182-5
Online ISBN: 978-3-642-32183-2
eBook Packages: EngineeringEngineering (R0)